Elanco Animal Health Inc (ELAN)
17.18
+0.20
(+1.18%)
USD |
NYSE |
May 17, 16:00
17.18
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health 1 Year Total Returns (Daily): 98.73% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 98.73% |
May 16, 2024 | 98.83% |
May 15, 2024 | 91.46% |
May 14, 2024 | 99.18% |
May 13, 2024 | 98.37% |
May 10, 2024 | 88.89% |
May 09, 2024 | 84.75% |
May 08, 2024 | 80.45% |
May 07, 2024 | 45.22% |
May 06, 2024 | 42.43% |
May 03, 2024 | 48.03% |
May 02, 2024 | 48.51% |
May 01, 2024 | 36.98% |
April 30, 2024 | 38.97% |
April 29, 2024 | 43.29% |
April 26, 2024 | 43.35% |
April 25, 2024 | 39.76% |
April 24, 2024 | 30.88% |
April 23, 2024 | 34.87% |
April 22, 2024 | 29.56% |
April 19, 2024 | 36.89% |
April 18, 2024 | 45.44% |
April 17, 2024 | 40.42% |
April 16, 2024 | 46.98% |
April 15, 2024 | 49.46% |
Date | Value |
---|---|
April 12, 2024 | 55.64% |
April 11, 2024 | 56.58% |
April 10, 2024 | 61.20% |
April 09, 2024 | 67.43% |
April 08, 2024 | 69.74% |
April 05, 2024 | 76.82% |
April 04, 2024 | 73.85% |
April 03, 2024 | 66.81% |
April 02, 2024 | 65.74% |
April 01, 2024 | 69.89% |
March 28, 2024 | 82.31% |
March 27, 2024 | 77.89% |
March 26, 2024 | 80.16% |
March 25, 2024 | 80.39% |
March 22, 2024 | 74.23% |
March 21, 2024 | 72.12% |
March 20, 2024 | 73.61% |
March 19, 2024 | 68.60% |
March 18, 2024 | 69.68% |
March 15, 2024 | 66.35% |
March 14, 2024 | 67.55% |
March 13, 2024 | 71.26% |
March 12, 2024 | 64.79% |
March 11, 2024 | 67.40% |
March 08, 2024 | 54.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-67.89%
Minimum
Mar 24 2023
102.3%
Maximum
Mar 18 2021
-10.55%
Average
-13.99%
Median
Feb 04 2022
1 Year Total Returns (Daily) Benchmarks
Zoetis Inc | -1.78% |
Dynavax Technologies Corp | -0.18% |
Geron Corp | 26.16% |
Esperion Therapeutics Inc | 34.09% |
Krystal Biotech Inc | 86.08% |